Solid Biosciences Inc. Cash Flow Breakdown
Cash flow breakdown shows where Solid Biosciences Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.
- Fiscal year ended 2025-12-31: from running the business, $156.29M went out.
- Fiscal year ended 2025-12-31: from investing, $58.45M went out.
- Fiscal year ended 2025-12-31: from financing, $194.45M came in.
- Fiscal year ended 2025-12-31: change in cash, $20.30M went out.
A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.
Each year (12 month)
| Fiscal year end | Running the business | From investing | New shares sold | Not split out | Change in cash |
|---|
| 2025-12-31 | -$156.29M | -$58.45M | $6.00K | $194.44M* | -$20.30M |
|---|
| 2024-12-31 | -$100.01M | -$16.09M | $457.00K | $121.98M* | $6.34M |
|---|
| 2023-12-31 | -$94.18M | $9.69M | $2.97M | | -$81.37M |
|---|
| 2022-12-31 | -$97.98M | $59.16M | $72.55M | $2.28M* | $36.01M |
|---|
| 2021-12-31 | -$77.76M | -$91.09M | $134.88M | | -$33.87M |
|---|
| 2020-12-31 | -$56.60M | $6.60M | $113.21M | $15.49M* | $78.70M |
|---|
| 2019-12-31 | -$92.71M | $24.52M | $49.33M | $8.55M* | -$10.32M |
|---|
| 2018-12-31 | -$70.20M | -$26.76M | | $131.51M* | $34.55M |
|---|
| 2017-12-31 | -$43.22M | $10.45M | | $77.08M* | $44.30M |
|---|
| 2016-12-31 | -$20.12M | -$4.05M | | $3.42M* | -$20.75M |
|---|
Each quarter (3 month)
| Quarter end | Running the business | From investing | New shares sold | Not split out | Change in cash |
|---|
| 2026-06-30 | -$52.59M* | -$133.59M* | $60.00K* | $48.41M* | |
|---|
| 2026-03-31 | -$47.23M | $44.76M | $18.00K | $239.01M* | $236.56M |
|---|
| 2025-12-31 | -$53.55M* | $47.01M* | $0.00* | $5.14M* | |
|---|
| 2025-09-30 | -$33.47M* | -$45.27M* | $0.00* | $1.18M* | |
|---|
| 2025-06-30 | -$37.41M* | -$32.73M* | $6.00K* | -$1.61M* | |
|---|
| 2025-03-31 | -$31.85M | -$27.46M | $0.00 | $189.73M* | $130.41M |
|---|
| 2024-12-31 | -$29.64M* | $38.57M* | $19.00K* | $6.92M* | |
|---|
| 2024-09-30 | -$23.71M* | -$10.99M* | $278.00K* | $2.98M* | |
|---|
| 2024-06-30 | -$21.47M* | -$5.18M* | $9.00K* | $4.99M* | |
|---|
| 2024-03-31 | -$25.19M | -$38.49M | $151.00K | $107.09M* | $43.56M |
|---|
| 2023-12-31 | -$20.82M* | $45.30M* | $435.00K* | | |
|---|
| 2023-09-30 | -$17.90M* | -$24.64M* | $0.00* | | |
|---|
| 2023-06-30 | -$27.46M* | -$48.23M* | | | |
|---|
| 2023-03-31 | -$28.00M | $37.26M | | | $9.27M |
|---|
| 2022-12-31 | -$34.48M* | $66.10M* | | $74.74M* | |
|---|
| 2022-09-30 | -$20.43M* | $14.91M* | | | |
|---|
| 2022-06-30 | -$15.88M* | -$59.59M* | | | |
|---|
| 2022-03-31 | -$27.19M | $37.74M | | | $10.57M |
|---|
| 2021-12-31 | -$20.87M* | $30.18M* | $0.00* | | |
|---|
| 2021-09-30 | -$18.42M* | -$72.51M* | $0.00* | | |
|---|
| 2021-06-30 | -$17.10M* | -$48.72M* | -$247.00K* | | |
|---|
| 2021-03-31 | -$21.37M | -$35.00K | $135.13M | | $113.75M |
|---|
| 2020-12-31 | $1.31M* | -$60.00K* | | | |
|---|
| 2020-09-30 | -$15.56M* | -$80.00K* | | | |
|---|
| 2020-06-30 | -$13.07M* | $322.00K* | | | |
|---|
| 2020-03-31 | -$29.27M | $6.42M | | | -$22.86M |
|---|
| 2019-12-31 | -$21.25M* | $2.85M* | $0.00* | | |
|---|
| 2019-09-30 | -$19.24M* | $3.96M* | | | |
|---|
| 2019-06-30 | -$26.30M* | $24.14M* | | | |
|---|
| 2019-03-31 | -$25.93M | -$6.45M | | | -$32.37M |
|---|
| 2018-12-31 | -$21.40M* | -$21.26M* | | | |
|---|
| 2018-09-30 | -$15.29M* | -$1.40M* | | | |
|---|
| 2018-06-30 | -$16.33M* | -$2.49M* | | | |
|---|
| 2018-03-31 | -$17.17M | -$1.61M | | $131.71M* | $112.93M |
|---|
| 2017-12-31 | -$13.98M* | -$2.81M* | | $53.76M* | |
|---|
| 2017-09-30 | -$9.44M* | -$7.32M* | | -$943.00K* | |
|---|
| 2017-06-30 | -$9.61M* | $13.61M* | | -$558.00K* | |
|---|
| 2017-03-31 | -$10.20M | $6.96M | | $24.82M* | |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
|---|
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
|---|
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
|---|